Next, we explored the effects of triple therapy on TIME and found that triple therapy increased the levels of GzmB in spleen and PB (Fig. 5E, F, Supplementary Fig. 6), whereas the addition of C-176 to triple therapy decreased its content in tumor (Fig. 5F). The gene discussed is GZMB; the disease is neoplasm.